Bridge Creek Capital Management LLC Abbott Laboratories Transaction History

Bridge Creek Capital Management LLC

$311 Million
Q1 2024

A detailed history of Bridge Creek Capital Management LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Bridge Creek Capital Management LLC holds 4,110 shares of ABT stock, worth $419,713. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,110

Previous 4,135 0.6%

Holding current value

$419,713

Previous $455,000 2.64%

% of portfolio

0.15%

Previous 0.16%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	SELL	$109.52 - $120.96 $2,738 - $3,024	-25 Reduced 0.6%	4,110 $467,000
Q4 2022 Jan 24, 2023	BUY	$95.06 - $111.52 $2,376 - $2,788	25 Added 0.61%	4,135 $0
Q3 2022 Oct 13, 2022	BUY	$96.76 - $112.03 $677 - $784	7 Added 0.17%	4,110 $398,000
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $2,052 - $2,502	18 Added 0.44%	4,103 $486,000
Q1 2021 Apr 09, 2021	SELL	$108.84 - $128.23 $7,074 - $8,334	-65 Reduced 1.57%	4,085 $490,000

Q3 2020 Oct 16, 2020	SELL	$91.64 - $111.29 $4,582 - $5,564	-50 Reduced 1.19%	4,150 $452,000
Q1 2020 Apr 14, 2020	SELL	$62.82 - $91.86 $3,957 - $5,787	-63 Reduced 1.48%	4,200 $331,000
Q2 2019 Jul 12, 2019	SELL	$72.88 - $85.0 $1,822 - $2,125	-25 Reduced 0.58%	4,263 $359,000
Q1 2019 Apr 05, 2019	BUY	$66.22 - $80.06 $20,726 - $25,058	313 Added 7.87%	4,288 $343,000
Q4 2018 Jan 18, 2019	SELL	$65.56 - $74.27 $3,278 - $3,713	-50 Reduced 1.24%	3,975 $288,000
Q3 2017 Oct 12, 2017	BUY	$48.06 - $53.64 $193,441 - $215,901	4,025	4,025 $215,000

Others Institutions Holding ABT

# of Institutions

3,131

Shares Held

1.29B

Call Options Held

8.43M

Put Options Held

8.71M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $179B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridge Creek Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridge Creek Capital Management LLC with notifications on news.

Account

Bridge Creek Capital Management LLC Abbott Laboratories Transaction History